SuperworthCardinal Health CAH
- Market cap
- $58B
- PE
- 34.5×
- 10y median 25.1×
- Forward PE
- 19.9×
- 10y median 13.5×
- Price to sales
- 0.2×
- EV/EBIT
- 23.0×
- Revenue, 12 months
- $254.2B
- +14% on a year ago
- Net margin
- 0.7%
- Free cash flow yield
- 7.8%
Cardinal Health trades at 34.5× trailing earnings, pricier than 72% of the last ten years. Revenue was $254.2B over the last twelve months, up 14% on a year earlier with a 1% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $54.6B+10% | $57.4B+12% | $54.9B+9% | $59.9B+12% | $52.3B−4% | $55.3B−4% | $54.9B+0% | $60.2B+1% | $64B+22% | $65.6B+19% | $60.9B+11% | $63.7B+6% | |
| Cost of revenue | $52.9B+10% | $55.6B+12% | $52.9B+9% | $58B+12% | $50.4B−5% | $53.3B−4% | $52.8B−0% | $58B+0% | $61.7B+23% | $63.2B+19% | $58.4B+11% | $61.1B+5% |
| Gross profit | $1.7B+8% | $1.9B+12% | $1.9B+8% | $1.9B+4% | $1.9B+9% | $1.9B+5% | $2.1B+10% | $2.2B+17% | $2.3B+22% | $2.4B+24% | $2.5B+18% | $2.6B+16% |
| SG&A | $1.2B−1% | $1.3B+7% | $1.3B+8% | $1.3B+4% | $1.3B+8% | $1.3B+3% | $1.3B+4% | $1.5B+16% | $1.5B+14% | $1.5B+15% | $1.5B+17% | $1.6B+10% |
| −$32M | $505M | $369M−36% | $401M+193% | $568M | $549M+9% | $730M+98% | $428M+7% | $668M+18% | $707M+29% | $509M−30% | $729M+70% | |
| Interest expense | $11M−56% | $3M−88% | $28M+0% | $9M−40% | $32M+191% | $35M+1067% | $74M+164% | $74M+722% | $80M+150% | $88M+151% | $101M+37% | $79M+7% |
| Pre-tax income | −$44M | $512M | $342M−37% | $391M+223% | $541M | $511M−0% | $665M+94% | $384M−2% | $598M+11% | $630M+23% | $392M−41% | $554M+44% |
| −$33M+3200% | $143M | $80M−59% | $158M−16% | $124M | $110M−23% | $157M+96% | $141M−11% | $144M+16% | $159M+45% | $12M−92% | $154M+9% | |
| Net income | −$12M | $368M | $261M−24% | $235M | $416M | $400M+9% | $506M+94% | $239M+2% | $450M+8% | $467M+17% | $399M−21% | $398M+67% |
| −$0.05 | $1.50 | $1.07−20% | $0.95 | $1.70 | $1.65+10% | $2.10+96% | $1.00+5% | $1.88+11% | $1.97+19% | $1.69−20% | $1.70+70% | |
| 249M−9% | 246M−6% | 245M−5% | 247M−4% | 245M−2% | 243M−1% | 241M−2% | 239M−3% | 239M−2% | 237M−3% | 236M−2% | 234M−2% |
EPS, diluted: 16 periods, Q4 FY09 to Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: 16 periods, Q4 FY09 to Q4 FY26: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY13 and Q4 FY18: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q1 FY27 | $66.6B | $66.3B to $66.9B | $2.95 | $2.91 to $2.99 | 9 |
| Q2 FY27 | $68.3B | $68B to $68.7B | $3.12 | $3.09 to $3.17 | 9 |
| Q3 FY27 | $63.8B | $63.2B to $64.3B | $3.36 | $3.32 to $3.40 | 6 |
| Q4 FY27 | $67.1B | $66.4B to $67.6B | $3.11 | $3.08 to $3.15 | 3 |
| Q1 FY28 | $70B | $69.3B to $70.6B | $3.33 | $3.28 to $3.36 | 3 |
| Q2 FY28 | $71.6B | $70.9B to $72.2B | $3.50 | $3.45 to $3.53 | 6 |
| Q3 FY28 | $66.7B | $66.1B to $67.2B | $3.81 | $3.76 to $3.85 | 8 |
| Q4 FY28 | $70B | $69.4B to $70.6B | $3.51 | $3.46 to $3.54 | 4 |
Peers
Companies in Medical - Distribution nearest Cardinal Health's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CAHCardinal Health | $58B | 34.5× | 25.1× | 19.9× | 0.2× | +14% | 0.7% |
| CORCencora | $63.2B | 24.6× | 21.1× | 17.0× | 0.2× | +5% | 0.8% |
| MCKMcKesson | $116.7B | 26.8× | 24.7× | 21.6× | 0.3× | +9% | 1.1% |
| HSICHenry Schein | $9.5B | 24.8× | 21.2× | n/m | 0.7× | +6% | 3.0% |
| Peer median | $63.2B | 24.8× | 21.2× | 19.3× | 0.3× | +6% | 1.1% |
More on Cardinal Health
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
Its groups
About
- Industry
- Medical - Distribution
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .